Board of Directors
Professor Hans Wigzell
Professor of Immunology, Karolinska Institutet. President of the Karolinska Institute between 1995–2003. Professor in the Department of Immunology at Uppsala University and Department of Immunology at Karolinska Institutet. In 1988, he became Director General of the National Bacteriological Laboratory in Stockholm. In 1990, he was elected Chairman of the EU Concerted Research Programme into AIDS vaccination and from 1990–1992 he was Chairman of the Nobel Committee for Medicine and Physiology. In 1993, he was appointed Secretary-General of the Swedish Institute for Infectious Disease Control. Between 1999 and 2007, he was Chief Scientific Advisor to the Swedish Government. Prof. Wigzell was Chairman of the Nobel Assembly at Karolinska Institutet in 2000. He has published more than 600 articles and is a member of the editorial boards of several international journals.
Birgitta Stymne Göransson
M.Sc. Chemical Engineering and Biotechnology from Royal Institute of Technology, Stockholm, MBA Harvard Business School, MA, USA. CEO of Memira Holding AB. Several senior management positions in Swedish industry including: Semantix, Telefos, Åhléns, Gambro and Excorim. Senior management consultant with McKinsey & Co and with Swedish Technical Attaches in Washington D.C. Board member of Elekta AB and Medivir AB.
Med.Dr. (h.c.), M.Sc.(Econ), Chairman of the Board for Affibody Holding AB, PledPharma AB and Tubulus AB, board member of Ferrosan Medical Devices AS. Former Chairman of the board Swedish Orphan Biovitrum AB (SOBI ), Orexo AB and Ferrosan AS. CEO of Kabi Pharmacia AB, Pharmacia AB and Astra Pharmaceutical Ltd. Numerous previous senior positions in the pharmaceutical industry.